Rigikal Alen 70mg/5600IU Tablet
Marketer
Synovion Laboratories Pvt Ltd
Salt Composition
Alendronic Acid (70mg) + Vitamin D3 (5600IU)
Overview Rigikal Alen 70mg/5600IU Tablet
Osteoporosis treatment involves Alen 70mg/5600IU tablets, which curb bone loss and promote bone density. This medication also strengthens supporting musculature. Specifically formulated for post-menopausal women, it rebuilds bone structure. Alen 70mg/5600IU tablets are most effective taken on an empty stomach, consistently at the same time daily, to aid adherence. Full therapeutic effects may take time; discontinue only upon physician instruction. This drug often forms part of a broader treatment plan, incorporating dietary adjustments and potentially other medications or supplements. Common, typically mild and self-resolving, side effects include headache, backache, musculoskeletal pain, indigestion, heartburn, and diarrhea. Persistent or worsening symptoms necessitate medical consultation. Your doctor can advise on managing side effects. Prior to commencing treatment, disclose all medical conditions and medications to your physician to ensure suitability. Regular monitoring of kidney function and mineral levels may be required. Excessive alcohol intake should be avoided due to its negative impact on bone health. Pregnant or breastfeeding individuals must consult their physician before using this medication.
Uses of Rigikal Alen 70mg/5600IU Tablet
Bone fragility
Major Benefits of Rigikal Alen 70mg/5600IU Tablet:
Consume Rigikal Alen 70mg/5600IU tablets precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
Common Side effects of Rigikal Alen 70mg/5600IU Tablet:
- Headache
- Musculoskeletal (bone, muscle or joint) pain
- Back pain
- Indigestion
- Diarrhea
- Heartburn
How to use Rigikal Alen 70mg/5600IU Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the 70mg/5600IU Rigikal Alen tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Rigikal Alen 70mg/5600IU Tablet works:
Osteoporosis is addressed by Rigikal Alen 70mg/5600IU tablets, a dual-action formulation combining alendronic acid (a bisphosphonate) and vitamin D3. Alendronic acid inhibits osteoclast activity, the bone-resorbing cells, thus bolstering bone strength and fracture resistance. Vitamin D3 contributes to bone health by enhancing calcium uptake and supporting the musculature crucial for fall prevention.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Rigikal Alen 70mg/5600IU tablets should be approached with care. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Rigikal Alen 70mg/5600IU Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Rigikal Alen 70mg/5600IU tablets while breastfeeding is likely safe. Available data from humans indicates minimal risk to the infant. However, if breastfeeding while taking this medication, infant blood calcium levels should be tracked for the initial two months postpartum.
DrivingUNSAFE
Driving ability may be impaired by side effects of Rigikal Alen 70mg/5600IU Tablets. Although generally well-tolerated, rare instances of dizziness, intense musculoskeletal pain, and ocular pain or inflammation have been reported, potentially impacting driving safety.
KidneySAFE IF PRESCRIBED
The use of Rigikal Alen 70mg/5600IU Tablets in patients with kidney disease appears to pose minimal risk. Preliminary findings indicate that altering the dosage of Rigikal Alen 70mg/5600IU Tablets may be unnecessary for this population. However, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Rigikal Alen 70mg/5600IU tablets in patients with liver disease is likely safe. Preliminary findings indicate dose modification may be unnecessary for this patient group. However, physician consultation is recommended.
What if you forget to take Rigikal Alen 70mg/5600IU Tablet :
Should you forget a Rigikal Alen 70mg/5600IU Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rigikal Alen 70mg/5600IU Tablet
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Pain Relievers |
3,018 People bought this recently